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Abstract
Background: Fatigue is common and has been shown to result in high economic costs to society. The aim of this
study is to compare the cost-effectiveness of two active therapies, graded-exercise (GET) and counselling (COUN)
with usual care plus a self-help booklet (BUC) for people presenting with chronic fatigue.
Methods: A randomised controlled trial was conducted with participants consulting for fatigue of over three
months’ duration recruited from 31 general practices in South East England and allocated to one of three arms.
Outcomes and use of services were assessed at 6-month follow-up. The main outcome measure used in the
economic evaluation was clinically significant improvements in fatigue, measured using the Chalder fatigue scale.
Cost-effectiveness was assessed using the net-benefit approach and cost-effectiveness acceptability curves.
Results: Full economic and outcome data at six months were available for 163 participants; GET=51, COUN=58
and BUC=54. Those receiving the active therapies (GET and COUN) had more contacts with care professionals and
therefore higher costs, these differences being statistically significant. COUN was more expensive and less effective
than the other two therapies. The incremental cost-effectiveness ratio of GET compared to BUC was equal to £987
per unit of clinically significant improvement. However, there was much uncertainty around this result.
Conclusion: This study does not provide a clear recommendation about which therapeutic option to adopt, based
on efficiency, for patients with chronic fatigue. It suggests that COUN is not cost-effective, but it is unclear whether
GET represents value for money compared to BUC.
Clinical Trial Registration number at ISRCTN register: 72136156
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Background
Fatigue has been shown to result in high economic costs
to society, especially because of its impact on employment
and the need for families and friends to spend time caring
for the individual [1,2]. Therapies including cognitive be-
haviour therapy (CBT), graded exercise therapy (GET)
and counselling, have been associated with reduced fa-
tigue in primary care patients six months later [3,4].
However, economic evaluations of these interventions
have reported inconclusive results, with considerable
uncertainty regarding cost-effectiveness estimates [5-7].
The aim of this paper is to compare the cost-
effectiveness of two of these active therapies, GET and
counselling (COUN) with usual GP care plus a self-help
booklet (BUC). The perspective taken is that of the
health service.
Method
Sample, setting and interventions
Exclusion and inclusion criteria of the clinical trial have
been described elsewhere [2,8]. Briefly, participants were
patients presenting to their general practitioners (GPs)
complaining of fatigue with a duration of more than
three months. They were randomised to one of the three
therapies considered: GET, COUN and usual GP care
plus a self-help booklet (BUC). For GET and COUN,
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two-week intervals at their local general practice, fol-
lowed by two telephone calls one month apart. For GET,
the durations of the initial and subsequent sessions were
45 and 30 minutes respectively and it consisted of super-
vised exercise by physiotherapists, adapted to each
patient’s current physical capacity, which is gradually
increased in duration according to a protocol designed
for patients with chronic fatigue. COUN patients were
offered 60 minute face-to-face sessions with a counsellor
registered with the British Association for Counselling
and Psychotherapy (BACP). The counselling style used
in this study followed the Rogerian client centred, non-
directive format that encouraged the patient to talk
through difficulties, and reflect on their experiences and
thoughts in order to understand themselves better, to ar-
rive at alternative understandings, to uncover the links
between current distress and past experience, and to
provide the conditions for growth and healing.
Outcomes
Assessments were made at baseline with follow-up at six
and twelve months. The primary clinical outcome was
the Chalder fatigue scale [9], which consists of 13 items
assessed using Likert scales (0,1,2,3) producing a total
score ranging between 0 and 33. For the purpose of the
economic evaluation we calculated the amount of clinic-
ally significant change by the six-month follow-up given
that use of services data was not available for the twelve
months follow-up. This was obtained by dividing the ac-
tual change in the Chalder fatigue scale total score by
four. Thus a value of one in the change in fatigue out-
come corresponds to a difference of four in the original
Chalder fatigue scale, assuming that a change of that
magnitude was clinically significant (CSI) [6]. This was
based in a consensus reached by clinicians in a previous
trial [10].
Service use and costs
The Client Service Receipt Inventory [11] was used to
retrospectively record service use for six months at the
follow-up time point and at baseline. Patients were asked
to provide details of health and social care services used
(including number of contacts and, where appropriate,
the average duration). Services included primary and
secondary healthcare contacts, complementary health-
care, social care and medication (only anti-depressant,
anti-anxiety and sleeping medication). These service use
data were combined with appropriate unit costs for
2006/2007 obtained from national sources [12-14]. The
unit costs of complementary and alternative therapies were
obtained from other publications and sources [15-17]. The
costs of different medicines were obtained from the
British National Formulary for the year 2006 [18]. For
GET and counselling the number of sessions attended
by each participant was recorded, assuming an average
duration of the sessions as previously stated. A nominal
figure of £5 per BUC patient was used to represent the
cost of the booklet used to enhance usual care.
Analysis
Analyses were carried out for those patients for whom
we had complete data in terms of clinical outcomes and
cost at the six-month follow–up. Multiple regression
was used to adjust for the following baseline characteris-
tics in all tests of differences in costs and clinical out-
comes: gender, age, whether the patient lived alone,
whether the patient had dependants, symptom level,
level of depression, level of anxiety, level of social func-
tioning, baseline fatigue score, number of months since
chronic fatigue began, and baseline health care cost. Re-
gression analysis using cost data frequently results in
non-normally distributed residuals. Therefore, boot-
strapping was used which involves resampling with re-
placement from the original sample a sufficiently large
number of times in order to approximate the distribu-
tion of the population from which the original data were
drawn [19]. In our analyses, 1000 samples were gener-
ated. Cost-effectiveness was then explored through the
calculation of incremental cost-effectiveness ratios
(ICER), defined as the difference in mean costs divided
by difference in mean effects [20]. Bootstrapped joint
distributions of incremental mean costs and effects for
the treatments was then used to calculate the probability
that each of the treatments is the optimal choice, subject
to a range of possible maximum values (ceiling ratio)
that a decision-maker might be willing to pay for a unit
improvement in outcome. Cost-effectiveness acceptabil-
ity curves are presented by plotting these probabilities
for a range of possible values of the ceiling ratio [21].
These curves incorporate the uncertainty that exists
around the estimates of expected costs and expected
effects associated with the interventions [22].
Ethical approval
Multi Centre Research Ethics Committee (MREC) ap-
proval; West MidlandsMREC/02/7/71. Local approval;
Lambeth, Southwark and Lewisham Primary Care Trusts
RDLSLG 142.
Results
Of the 222 individuals who were randomised, full eco-
nomic and outcome data at six-months follow-up were
available for 163 participants (73%) (Figure 1. The Flow
of Participants). Most of them were women (81%) with
an average age of 41 years and a median duration of fa-
tigue of two years. There were no significant statistical
differences in clinical variables at baseline between
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without. However, the former were older and had a
lower average duration of fatigue. The probability of not
having completed data at six months did not depend on
treatment arm assigned.
Table 1 details the use of resources for each treatment
group. Participants receiving the active therapies had
more contacts with care professionals than the usual
care participants, both in the percentage of those who
used these services and in the number of contacts.
COUN patients had a slightly higher use of services than
the GET patients. The cost of services reflects these ser-
vice use differences (Table 1). The difference in the
intervention costs was due to a more expensive cost of
counselling sessions as a result of their longer duration.
Table 1 also shows average Chalder scores at baseline
and at six months. The improvement over that period is
almost identical for the BUC and COUN groups, while
those patients receiving GET, on average, had a slightly
greater improvement.
Comparisons of total costs and outcomes between
the three groups are shown in Table 2. The adjusted
differences in costs and outcomes obtained between
the three treatment arms show that COUN is signifi-
cantly more expensive and non-significantly less effect-
ive (based on the Chalder fatigue scale) than the other
two interventions. In economic terms COUN is ‘domi-
nated’ by GET and BUC. GET is more expensive than
Enrolment      Referred  to  trial 
N = 324  
Did not meet inclusion 
criteria (n = 34) 
Declined, no reason 
given (n = 42) 
Declined, no time or no 
wish for treatment (n = 
24) 
Allocation      Eligible  for  trial 
N = 224 
ExcludedN=100
Withdrawn
N = 2 
Randomization   BUC 
N = 75 (33.8) 
 GET 
N = 71 (32) 
 COUN 
N = 76 (34.2) 
Baseline assessment    75 (100%) 
completed 
 71  (100%) 
completed 
 76  (100%) 
Completed 
Full 
Treatment 
 75  (100%) 
received BUC 
 38  (53.5%) 
attended 8 sessions 
 42  (55.3%) 
attended 8 sessions 
6-month follow-up 
 n=163 
 54  (72%) 
completed measures 
 51  (71.8%) 
completed measures 
 58  (76.3%) 
completed measures 
Figure 1 The flow of participants.
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incremental cost-effectiveness ratio for the comparison
of these two interventions is £987 per unit of CSI (gain
of four points in the Chalder score) obtained as a re-
sult of GET. The uncertainty associated with this result
is indicated in the cost-effectiveness acceptability curve
(Figure 2. Cost-effectiveness acceptability curve of
interventions evaluated.), where the probabilities of the
interventions being cost effective are shown for differ-
ent monetary values assigned to a gain of a unit of
outcome (CSI). If this monetary value or willingness to
pay for a CSI is equal to £1000, there is a 55% chance
that GET is the most cost- effective option and just a
5% that COUN is the most cost-effective option. When
the value placed on a CSI is equal to £2500, the prob-
ability that GET is the most cost-effective option
reaches 63%. Analyses beyond this value (up to a will-
ingness to pay of £100,000 for a CSI) found that the
likelihood of GET being the intervention more cost-
effective did not rise above 65% (and the value for
COUN did not reach 17%).
Discussion
Previous studies have shown that the majority of costs
associated with chronic fatigue are hidden or indirect,
such as informal care and lost productivity [2]. Never-
theless, in the current context of cost containment and
efficiency savings, a narrower focus on healthcare costs
as the one adopted in the present study is still relevant.
The analysis of the outcome results at six months did
not find statistically significant differences between the
three treatments after adjusting by baselines characteris-
tics. Therefore, the superiority of any treatment in clin-
ical terms cannot be established. On the other hand,
there were statistically significant differences between
the costs for the three interventions.
The combination of outcomes and costs shows that
counselling is dominated by the other two options.
Therefore, it might be the case that the choice is
reduced to that between GET and BUC. GET is more
expensive and more effective and, therefore, it is a value
judgement as to whether this represents value for
money. The CEAC illustrates that the probability that
Table 1 Average use of services, average costs (£ 2006/07) and average Chalder fatigue scale score
BUC (N=54) GET (N=51) COUN (N=58)
Professional %
1 Contacts
2 (sd) Cost (£) %
1 Contacts
2 (sd) Cost (£) %
1 Contacts
2 (sd) Cost (£)
GP 70 3.1 (1.91) 102.9 84 3.5 (3.20) 140.6 83 3.9 (2.46) 154.7
Other doctor 28 1.6 (0.74) 29.8 29 3.1 (2.34) 59.0 48 1.8 (1.16) 67.4
Neurologist 2 1.0 (−) 2.9 6 1.3 (0.58) 12.2 5 3.0 (2.00) 24.2
Psychiatrist 0 . 0.0 8 2.8 (1.71) 30.2 10 3.2 (2.48) 45.9
Nurse 24 1.2 (0.38) 2.2 24 1.3 (0.62) 2.4 31 2.3 (4.23) 5.7
Other care professional 22 6.6 (5.87) 49.2 35 4.6 (4.79) 44.9 22 4.5 (5.08) 33.7
Homeopath/ herbalist 4 4.5 (2.12) 9.1 8 3.5 (3.11) 15.0 9 6.4 (5.22) 30.2
Medication 33 – 11.9 31 – 13.3 29 – 12.0
Therapy – 5.0 – 6.7 (2.4) 156.1 – 6.8 (2.3) 277.1
Total cost 212.9 473.6 650.8
Chalder score Baseline 23.85 24.67 24.78
Chalder score 6 months 15.30 14.61 16.16
Improvement 8.56 10.06 8.62
GET=graded exercise therapy, BUC=booklet plus usual care, COUN=counselling,
1. percentage of participants in each treatment group using the service. 2. average number ofcontacts for those who at least had one.
Table 2 Adjusted
1 differences in costs and outcomes and incremental cost-effectiveness ratios
GET vs BUC COUN vs BUC GET vs COUN
Difference (95%CI) p Difference (95%CI) p Difference (95%CI) p
Costs differences 261(141 to 382) <0.001 423 (288 to 559) <0.001 −202 (−362 to −43) 0.013
Chalder improvements differences 1.1 (−2.3 to 4.4) 0.530 −0.1 (−3.1 to 2.9) 0.969 0.7 (2.6 to −4.0) 0.663
ICER per CSI 987 COUN dominated strategy COUN dominated strategy
GET=graded exercise therapy, BUC=booklet plus usual care, COUN=counselling, ICER=incremental cost-effectiveness ratio, CSI=clinically significant
improvement.
1. adjusted by the following baseline characteristics: gender, age, whether the patient lived alone, whether the patient had dependants, symptom level, level of
depression, level of anxiety, level of social functioning, baseline fatigue score, number of months since chronic fatigue began, and baseline health care cost.
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reach a convincing level even when a high level is placed
on a clinically significant improvement. If society values
such an outcome at £2500 then there is over a 60% like-
lihood that GET is cost-effective. This uncertainty has
been found in previous studies that have analysed the
cost-effectiveness of these or alternative interventions
[5,6]. Chisholm et al. found that counselling was cheaper
than cognitive behavioural therapy (CBT) while in the
study by McCrone et al., CBT was also more expensive
than the other active therapy (graded exercise). Never-
theless, a clear result as to which intervention was more
cost-effective was not reported. These studies were also
conducted in primary care with a design very similar to
the one presented here although the number of partici-
pants in these studies were slightly lower.
A more comprehensive analysis of outcomes trial data
[8], including the analysis of effectiveness data at
12 months, found that there were no significant differ-
ences in change scores between the three groups at the
6- or 12-month assessments. This analysis also found
that, compared to BUC, those treated with graded exer-
cise or counselling therapies were more satisfied at
1 year. Patients with fatigue have reported low levels of
satisfaction with diagnosis and management in primary
care. Satisfaction is an important and remunerated out-
come in the National Health Service, but it is not clear
how this can be assessed against increased cost.
Limitations
First, data collected under experimental conditions may
be different from data collected under routine conditions.
However, we believe that such bias is minimal in the
present study given that patients were drawn from the
same practices and the same instruments were used for
assessment. Second, reliance on patient self-report might
result in some inaccuracies in service use measures. While
the schedule used is well developed and has been used in
numerous other studies, it may still be the case that for
some patients recall was difficult and this would have led
to inaccuracies. A number of studies have though sug-
gested that patient recall of service use can be acceptable
[23-25]. Another study noted a difference between self-
report and administrative records, but pointed out that it
was unclear which was more accurate [26]. Third, a unit
change on the fatigue scale is difficult to interpret. This is
addressed to some extent by using a four-point change to
represent clinical significance. However, this is in itself
somewhat arbitrary and still presents a challenge for inter-
pretation by those not closely involved in the care of this
patient group. Indeed, the self-reported nature of the
Chalder Fatigue Scale could prove problematic as it
requires respondents to compare themselves with how
they were previously (termed as usual) and they may be
unsure as to this. The duration of the follow-up period
also imposes limitations to the significance of the results
of the study. Availability of economic data for the follow-
up of a year would have increased the validity and rele-
vance of the results. Our analysis would also benefit from
a wider perspective that includes informal care and prod-
uctivity costs. It was not feasible to use quality-adjusted
life years (QALYs) as an outcome measure, as planned in
the trial protocol, and this is also a limitation. This was
caused by unexpected unavailability of EQ-5D question-
naire data for the six months follow-up. Finally, there were
incomplete data for 27 % of the individuals who were ran-
domised. It was decided not to conduct imputations given
that there were limited data to do this.
Conclusion
No clear economic advantage of any of the therapies for
the management of patients with chronic fatigue was
found in our study. Nevertheless, it does indicate that
COUN is not cost-effective. With regards to GET, this
intervention appears slightly more effective than BUC
but this improvement comes at a higher cost. The ana-
lyses suggest that the value of a clinically significant im-
provement needs to be relatively high for GET to be
declared the most cost-effective intervention.
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